Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DMFGLXB)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
Phensuximide; Milontin; Succitimal; Lifene; Phenylsuximide; Epimid; Fensuccimide; Fenosuccimide; Phensuximidum; 86-34-0; phensuccimide; Fensuximida; Phensuximid; Methylphenylsuccinimide; Fensuccimide [DCIT]; Succinimide, N-methyl-2-phenyl-; Phensuximidum [INN-Latin]; Fensuximida [INN-Spanish]; 1-methyl-3-phenylpyrrolidine-2,5-dione; Mirontin; Milonton; N-Methyl-alpha-phenylsuccinimide; PM 334; N-Methyl-2-phenylsuccinimide; Milontin (TN); 1-Methyl-3-phenylpyrrolidin-2,5-dione; 1-Methyl-3-phenyl-2,5-pyrrolidinedione; EINECS 201-664-6
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Bone
Osteosarcoma
Breast
Breast adenocarcinoma
Cervix
Cervical adenocarcinoma
Colon
Colorectal adenocarcinoma
Kidney
Normal (Immortalized)
Lung
Lung adenocarcinoma
Non-small cell lung carcinoma
Pancreas
Pancreatic carcinoma
Prostate
Prostate carcinoma
Skin
Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
